Dr Adrian Potts, CEO, Discusses AGM's Graphene Technologies and the Markets being Targeted

• Home
• Products
  • Graphene nanoplatelets
  • Standard Genable® dispersions
  • Development dispersions
• Applications
  • Paints and coatings
  • Polymers and composites
  • Lubricants and functional fluids
  • Thermal Pastes
  • Batteries and energy storage
• About us
  • Company history
  • Board of Directors
  • Careers
• Investor relations
  • Understanding our business
  • Detailed share price
  • RNS announcements
  • Financial calendar
  • Reports and presentations
  • Major shareholders
  • Corporate governance
    • Audit Committee
    • Remuneration Committee
    • Nomination Committee
    • Stakeholder Engagement
    • Ethics and Compliance
    • Executive Committee
    • Role of the Board
    • Board Evaluation
    • AGM Votes
  • Advisors and registrars
  • AIM Rule 26
  • Warning to shareholders
• News and events
  • News
  • Events calendar
  • RNS alerts
  • AGM’s Newsletter
• Contact
  • Distributors
• Search
• Sitemap
• Privacy
• Hidden drafts
• Accessibility
• Cookies
• Terms

15 April 2019

Dr Adrian Potts, Applied Graphene Materials’ (AGM) CEO discusses the specific differentiators of its graphene technologies and the markets being targeted through 120 different customer engagements. He also discusses the pathway towards commercialisation and gives some detail on activities in the paints and coatings world, where the first products are on the cusp of commercial realisation. He also discusses what commercial and technical milestones investors should look for as the business executes its strategy, the key changes made since his arrival as CEO last year and the company’s balance sheet and cash burn profile.

Back to news.